Pediatrics. 1998 Jan;101(1 Pt 1):129-33.
The purpose of this statement is to inform physicians of a modification in the recommendation of the appropriate age for routine administration of the second dose of measles-mumps-rubella (MMR) vaccine. The implementation of the two-dose measles vaccine schedule has improved the control of measles, but some outbreaks continue to occur in school children, although >/= to 95% of children in school have received one dose of vaccine. Because most measles vaccine failures are attributable to failure to respond to the first dose, that all children receive two doses of measles-containing vaccine is essential for the control of measles. Routine administration of the second dose of MMR vaccine at school entry (4 to 6 years of age) will help prevent school-based outbreaks. Physicians should continue to review the records of all children 11 to 12 years of age to be certain that they have received two doses of MMR vaccine after their first birthday. Documenting that all school children have received two doses of measles-containing vaccine by the year 2001 will help ensure the elimination of measles in the United States and contribute to the global effort to control and possible eradicate measles.
本声明旨在告知医生，麻疹-腮腺炎-风疹（MMR）疫苗第二剂常规接种的适宜年龄建议有所调整。两剂次麻疹疫苗接种计划的实施改善了麻疹防控情况，但尽管学校中≥95%的儿童已接种一剂疫苗，仍有一些麻疹疫情在学童中持续发生。由于大多数麻疹疫苗接种失败是由于对第一剂疫苗无反应，因此所有儿童接种两剂含麻疹成分疫苗对于控制麻疹至关重要。在入学时（4至6岁）常规接种第二剂MMR疫苗将有助于预防学校内的麻疹疫情。医生应继续检查所有11至12岁儿童的接种记录，以确保他们在满1岁后已接种两剂MMR疫苗。记录所有学童在2001年前已接种两剂含麻疹成分疫苗，将有助于确保在美国消除麻疹，并为全球控制和可能根除麻疹做出贡献。
